COG Phase III Study

The COG Phase III Study refers to a clinical trial organized by the Children's Oncology Group (COG), which focuses on improving treatments for childhood cancers. Phase III studies compare a new treatment or drug to the standard care, involving a larger group of children to determine effectiveness and safety. This phase aims to gather more data on how well the treatment works and whether it has fewer side effects. The results help inform doctors and researchers about the best possible treatment options for children with cancer.